Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RADFORMIN: Metformin with Radiotherapy in Stage III NSCLC
NCT04170959Phase 2Terminated
- Sponsor
- Antwerp University Hospital
- Start
- Jul 2018
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in non-small cell lung cancer (NSCLC), sponsored by Antwerp University Hospital. Started Jul 2018; status: terminated.
02
Drugs
metformin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT04170959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04170959.